Dactinomycin — Drug Intelligence | 4 EU Trials

Filter these 4 trials by condition, phase, country and more.

4 Registered trials

4 Recruiting

0 Completed trials

3 Sponsors

17 Countries

Phase III

Phase II

Phase I/II

Phase III: 2 Phase II: 1 Phase I/II: 1

Oversight events:

2 urgent safety measures across 1 trial

Indications tested

4 total

Improving public cancer care by implementing precision medicine in Norway Recruiting

2023-507894-16-00 Phase II 1 country Oslo University Hospital HF
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Phase I/II 16 countries The University Of Birmingham
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT) Recruiting

2022-501456-28-00 Phase III 12 countries GPOH gGmbH
SIOP RANDOMET 2017 Recruiting

2023-508926-91-00 Phase III 10 countries GPOH gGmbH

Showing 1–4 of 4 trials